Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/32209
Title: Expression of steroid receptor coactivators in cultured cells from paired myometrial and fibroid tissues.
Authors: Gargett C.E.;Fuller P.J.;Hussein-Fikret S.
Institution: (Gargett) Monash University, Department of Obstetrics and Gynaecology, Monash Medical Centre, 246 Clayton Rd, Clayton, Vic. 3168, Australia
Issue Date: 18-Oct-2012
Copyright year: 2005
Publisher: Elsevier USA (6277 Sea Harbor Drive, Orlando FL 32862 8239, United States)
Place of publication: United States
Publication information: Journal of the Society for Gynecologic Investigation. 12 (6) (pp 445-451), 2005. Date of Publication: September 2005.
Abstract: OBJECTIVES: Fibroid tumor growth in the myometrium appears to be regulated by estrogens but the role of estrogen receptor (ER) coregulators, such as the steroid receptor coactivator (SRC) family members, in fibroid growth is currently unknown. The aims of this study were to compare the expression of the SRC-1, SRC-2, and SRC-3 coactivators between fibroids and normal myometrium in pure populations of cultured smooth muscle cells (SMC) and microvascular endothelial cells (MEC), and also between both cell types, and to identify any relationship between the SRC expression profiles and the known ER status of the SMC and MEC samples examined in this study. METHOD(S): Reverse transcriptase-polymerase chain reaction (RT-PCR) coupled with Southern blot analysis was used to derive a semiquantitative estimate of the relative levels of SRC-1, SRC-2, and SRC-3 expression in pure populations of SMC (>98% alpha-smooth muscle actin [SMA]+) and MEC (>99% CD31 +) isolated and cultured from eight samples of paired human myometrial and fibroid tissue. RESULT(S): The mean levels of SRC-1, SRC-2, and SRC-3 were each similar in normal myometrium compared to fibroids for SMC and also for MEC. However, SRC-1, SRC-2, and SRC-3 levels were each significantly higher in SMC compared to MEC from both myometrial and fibroid samples, although for SRC-3 there was a trend for higher levels in myometrial samples that did not reach significance. While all SMC samples expressed ERalpha and high coactivator levels, there does not appear to be a relationship between coactivator expression levels and the presence or absence of ERalpha in MEC samples. CONCLUSION(S): Coactivators may be more important in ERalpha-mediated growth of SMC than for MEC. Although the SRC family members are likely to play a role in the response of fibroid SMC to estrogen, via ERalpha, changes in their levels do not appear to contribute to the increased sensitivity of fibroid SMC to estrogen. Copyright © 2005 by the Society for Gynecologic Investigation.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.jsgi.2005.04.008
PubMed URL: 15979354 [http://www.ncbi.nlm.nih.gov/pubmed/?term=15979354]
ISSN: 1071-5576
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/32209
Type: Article
Appears in Collections:Articles

Show full item record

Page view(s)

4
checked on May 17, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.